Professional articles

by EUROIMMUN

PCR ALLOWS RAPID, DIFFERENTIATED DERMATOMYCOSIS DIAGNOSTICS

Featured in Clinical Laboratory International

The diagnosis of fungal infections of the skin and nails has undergone a paradigm shift in recent years. Traditional culturing methods have in many cases ...

TRACKING DOWN MYCOSES BY GENE DETECTION - NEW AND CLASSICAL PATHOGENS

Featured in Derm - Praktische Dermatologie

The spectrum of cutaneous mycoses and their pathogens is now more diverse and wide-ranging than ever before.

ANTI-PLA2R: A NON-INVASIVE SEROLOGICAL BIOMARKER IN LIEU OF BIOPSY

Featured in Omnia Health Magazine

Accurate diagnosis of the autoimmune kidney disease primary membranous nephropathy (pMN) is crucial for therapy decision-making. Autoantibodies against phospholipase ...

LABORATORY DIAGNOSTICS IN POLYCYSTIC OVARY SYNDROME

Featured in Omnia Health Magazine

Polycystic ovary syndrome (PCOS) is a common endocrine and reproductive disorder of women, which can result in menstrual complications, fertility problems and other ...

NEW AUTOMATION TECHNOLOGIES AT THE VANGUARD OF IFA DIAGNOSTICS

Featured in Clinical Laboratory International

EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. Continuing this long tradition, the company ...

STANDARDISATION OF BIOMARKER MEASUREMENTS IN ALZHEIMER’S DISEASE DIAGNOSTICS

Featured in Omnia Health Magazine Jan/Feb 2022

Alzheimer’s disease is the most common cause of dementia in old age, accounting for 60 to 70 per cent of cases

MULTIPARAMETER AUTOANTIBODY TESTING IN AUTOIMMUNE NEUROLOGICAL DISEASES

Featured in Clinical Laboratory International

In recent years, there has been a growing understanding of the pathology of autoimmune neurological disorders, and the identification of the causal ...

FROM BIOCHIPS TO ARTIFICIAL INTELLIGENCE – DEFINING NEW HORIZONS IN IFA

Featured in Clinical Laboratory International

EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. CLI talked to Dr. Panagiotis Grypiotis, Head ...

Back to top